From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Clinical data
ATC code
  • none
Legal status
Legal status
CAS Number
PubChem CID
Chemical and physical data
Molar mass368.469 g/mol g·mol−1
3D model (JSmol)

Pentamorphone (14β-pentylaminomorphinone, RX-77989) is a semi-synthetic opiate derivative related to compounds such as morphine, hydromorphone and oxymorphone. Developed in 1984, it is a potent opioid analgesic several times stronger than fentanyl, and with a similarly fast onset of effects and short duration of action.[1][2] It was found to produce relatively little respiratory depression compared to other potent opioid agonists,[3] but its analgesic effects were somewhat disappointing in human trials,[4] and while pentamorphone had some slight advantages over fentanyl[5] these were not sufficient to warrant its introduction into clinical use.


  1. ^ Glass PS, Camporesi EM, Shafron D, Quill T, Reves JG. Evaluation of pentamorphone in humans: a new potent opiate. Anesthesia and Analgesia. 1989 Mar;68(3):302-7. PMID 2465708
  2. ^ Rudo FG, Wynn RL, Ossipov M, Ford RD, Kutcher BA, Carter A, Spaulding TC. Antinociceptive activity of pentamorphone, a 14-beta-aminomorphinone derivative, compared to fentanyl and morphine. Anesthesia and Analgesia. 1989 Oct;69(4):450-6. PMID 2476953
  3. ^ Afifi MS, Glass PS, Cohen NA, Shook JE, Camporesi EM. Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone. Anesthesia and Analgesia. 1990 Oct;71(4):377-83. PMID 1698039
  4. ^ Wong HY, Parker RK, Fragen R, White PF. Pentamorphone for management of postoperative pain. Anesthesia and Analgesia. 1991 May;72(5):656-60. PMID 1708214
  5. ^ Kelly WB, Howie MB, Romanelli VA, Duarte JA, Rezaei H, McSweeney TD. A comparison of pentamorphone and fentanyl in balanced anaesthesia during general surgery. Canadian Journal of Anesthesia. 1994 Aug;41(8):703-9. PMID 7522977